{"id": "1387579890694860805", "creation": 1619659800.0, "user_id": "1211892441529241601", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 2, "reply_count": 0, "like_count": 3, "quote_count": 1}}, "text": "#CanSino Biologics (CanSinoBIO) is expected to increase the annual production capacity of its recombinant adenovirus vector #COVID19 #vaccine-the only single-dose vaccine approved in #China-to 200 to 300 mln doses after its 3rd plant comes into full operation. https://t.co/2SH1RHvSc4", "first_save": 1634559108.199414, "hashtags": ["#CANSINO", "#COVID19", "#VACCINE", "#CHINA"]}